Saudi Arabia Nuclear Medicine Market Size & Outlook
Global Market
Related Markets
Saudi Arabia nuclear medicine market highlights
- The Saudi Arabia nuclear medicine market generated a revenue of USD 159.6 million in 2025 and is expected to reach USD 260.0 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 5.5% from 2026 to 2033.
- In terms of segment, diagnostics was the largest revenue generating product in 2025.
- Diagnostics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2025 | USD 159.6 million |
| Market revenue in 2033 | USD 260.0 million |
| Growth rate | 5.5% (CAGR from 2026 to 2033) |
| Largest segment | Diagnostics |
| Fastest growing segment | Diagnostics |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.8% of the global nuclear medicine market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, UAE nuclear medicine market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 292.7 million by 2033.
Saudi Arabia is one of the richest countries in GCC. The Ministry of Health in Saudi Arabia offers free treatment to government employees, Saudi nationals, and pilgrims. About 9.2 million expatriates in Saudi Arabia receive medical services from private hospitals.
Hospitals in Saudi Arabia are developing new nuclear medicines. For instance, in 2017, King Fahad Hospital in Jeddah received permission to practice nuclear medicine and its diagnostic radiology department received a license from the National Center for Radiation Protection for the use of radioactive substances in medical diagnosis & treatment.
The number of private hospitals in Saudi Arabia is expected to increase with the growing number of expatriates. In addition, the demand for radiopharmaceuticals is likely to increase in this country owing to factors such as rise in the number of private hospitals, increase in the per capita healthcare expenditure, and increased application of radiopharmaceuticals for diagnostic purposes.
No credit card required*
Publish Date: Jun 17, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| Mallinckrodt PLC Ordinary Shares - New | View profile | 2,700 | College Business and Technology Park, Cruiserath, Blanchardstown, Dublin, Ireland, 15 | www.mallinckrodt.com |
| Eckert & Ziegler Bebig SA | View profile | 501-1000 | Seneffe, Hainaut, Belgium, Europe | www.ezag.com/home/ |
| Nordion | View profile | 251-500 | Kanata, Ontario, Canada, North America | nordion.com |
| Bracco | View profile | 1001-5000 | Milan, Lombardia, Italy, Europe | www.bracco.com |
| Lantheus Holdings Inc | View profile | 834 | 201 Burlington Road, South Building, Bedford, MA, United States, 01730 | www.lantheus.com |
| Jubilant Pharmova | View profile | 10001+ | Noida, Uttar Pradesh, India, Asia | www.jubilantpharmova.com |
| Iren SpA | View profile | 10,000 | Via Nubi di Magellano, 30, Reggio Emilia, Italy, 42123 | www.gruppoiren.it |
| Abliva AB | View profile | 6 | Scheeletorget 1, Medicon Village, Lund, Sweden, 223 81 | www.abliva.com |
Saudi Arabia Nuclear Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Nuclear Medicine Market Outlook will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 86.34% in 2025.
Horizon Databook has segmented the Saudi Arabia nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2021 to 2033.
Saudi Arabia is one of the richest countries in GCC. The Ministry of Health in Saudi Arabia offers free treatment to government employees, Saudi nationals, and pilgrims. About 9.2 million expatriates in Saudi Arabia receive medical services from private hospitals.
Hospitals in Saudi Arabia are developing new nuclear medicines. For instance, in 2017, King Fahad Hospital in Jeddah received permission to practice nuclear medicine and its diagnostic radiology department received a license from the National Center for Radiation Protection for the use of radioactive substances in medical diagnosis & treatment.
The number of private hospitals in Saudi Arabia is expected to increase with the growing number of expatriates. In addition, the demand for radiopharmaceuticals is likely to increase in this country owing to factors such as rise in the number of private hospitals, increase in the per capita healthcare expenditure, and increased application of radiopharmaceuticals for diagnostic purposes.
- Saudi Arabia Nuclear Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Diagnostics
- Therapeutics
- Saudi Arabia Nuclear Medicine Market Application Outlook (Revenue, USD Million , 2021-2033)
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Pulmonary Scans
- Urology
- Other
- Saudi Arabia Nuclear Medicine Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Diagnostic Centers
- Others
Reasons to subscribe to Nuclear Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Nuclear Medicine Market Outlook databook
- Our clientele includes a mix of Nuclear Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Nuclear Medicine Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Nuclear Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Saudi Arabia Nuclear Medicine Market, 2021-2033 (US$M)
Saudi Arabia nuclear medicine market statistics, by product, 2021-2033 (US$M)
